Drew Angerer/Getty Images
By Andrew Joseph
May 7, 2026
Europe Correspondent
Andrew Joseph
The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.
Drew Angerer/Getty Images
By Andrew Joseph
May 7, 2026
Europe Correspondent
Andrew Joseph

Angelini to buy Catalyst in $4B play for rare neuro drugs

Angelini Pharma acquista americana Catalyst per 4,1 miliardi - Ultima ora - Ansa.it

Angelini Pharma acquista americana Catalyst per 4,1 miliardi - Notizie - Ansa.it

Angelini Pharma acquista l’americana Catalyst per 4,1 miliardi di dollari

Shopping americano per Angelini: scommessa da 3,5 miliardi su Catalyst